{"id":"https://openalex.org/W4388035153","doi":"https://doi.org/10.1097/cji.0000000000000491","title":"Durvalumab-induced Pure White Cell Aplasia","display_name":"Durvalumab-induced Pure White Cell Aplasia","publication_year":2023,"publication_date":"2023-10-30","ids":{"openalex":"https://openalex.org/W4388035153","doi":"https://doi.org/10.1097/cji.0000000000000491","pmid":"https://pubmed.ncbi.nlm.nih.gov/37904601"},"language":"en","primary_location":{"id":"doi:10.1097/cji.0000000000000491","doi":"https://doi.org/10.1097/cji.0000000000000491","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cji.0000000000000491","pdf_url":null,"source":{"id":"https://openalex.org/S177451610","display_name":"Journal of Immunotherapy","issn_l":"1524-9557","issn":["1524-9557","1537-4513"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Immunotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072240352","display_name":"Ji Zheng Lin","orcid":"https://orcid.org/0000-0001-5003-3095","observed_orcids":["https://orcid.org/0000-0001-5003-3095"]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ji Lin","raw_affiliation_strings":["Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX","institution_ids":["https://openalex.org/I919571938"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Paola Rodriguez-Martinez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Paola Rodriguez-Martinez","raw_affiliation_strings":["Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX","institution_ids":["https://openalex.org/I919571938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038157897","display_name":"Thein Hlaing Oo","orcid":"https://orcid.org/0000-0002-5201-731X","observed_orcids":["https://orcid.org/0000-0002-5201-731X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thein Hlaing Oo","raw_affiliation_strings":["Section of Benign Hematology, The University of Texas M.D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Benign Hematology, The University of Texas M.D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087834877","display_name":"E Shuyu","orcid":"https://orcid.org/0009-0009-1998-1172","observed_orcids":["https://orcid.org/0009-0009-1998-1172"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shuyu E","raw_affiliation_strings":["Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028591457","display_name":"Jeffrey L. Jorgensen","orcid":"https://orcid.org/0000-0002-1875-2986","observed_orcids":["https://orcid.org/0000-0002-1875-2986"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey Jorgensen","raw_affiliation_strings":["Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046413977","display_name":"Cristhiam Mauricio Rojas Hernandez","orcid":"https://orcid.org/0000-0003-3890-3929","observed_orcids":["https://orcid.org/0000-0003-3890-3929"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cristhiam M. Rojas-Hernandez","raw_affiliation_strings":["Section of Benign Hematology, The University of Texas M.D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Benign Hematology, The University of Texas M.D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5072240352"],"corresponding_institution_ids":["https://openalex.org/I919571938"],"apc_list":null,"apc_paid":null,"fwci":0.361,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.53919202,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"47","issue":"1","first_page":"7","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/durvalumab","display_name":"durvalumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7820000052452087},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.8550000190734863},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.8690000176429749},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.828000009059906},{"id":"https://openalex.org/keywords/filgrastim","display_name":"filgrastim","score":0.8859999775886536},{"id":"https://openalex.org/keywords/prednisone","display_name":"prednisone","score":0.9559999704360962},{"id":"https://openalex.org/keywords/cyclosporine","display_name":"cyclosporine","score":0.9940000176429749},{"id":"https://openalex.org/keywords/immunosuppressive-therapy","display_name":"immunosuppressive therapy","score":0.9729999899864197}],"concepts":[{"id":"https://openalex.org/C2777742743","wikidata":"https://www.wikidata.org/wiki/Q19904005","display_name":"Durvalumab","level":5,"score":0.905185341835022},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7502433657646179},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6436545848846436},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.5418040156364441},{"id":"https://openalex.org/C2778720950","wikidata":"https://www.wikidata.org/wiki/Q424972","display_name":"Prednisone","level":2,"score":0.5046011209487915},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.49152716994285583},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.46267908811569214},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4504094421863556},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2749350070953369},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2701990008354187},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2049471139907837},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.12791332602500916},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1097/cji.0000000000000491","doi":"https://doi.org/10.1097/cji.0000000000000491","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cji.0000000000000491","pdf_url":null,"source":{"id":"https://openalex.org/S177451610","display_name":"Journal of Immunotherapy","issn_l":"1524-9557","issn":["1524-9557","1537-4513"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Immunotherapy","raw_type":"journal-article"},{"id":"pmid:37904601","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37904601","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of immunotherapy (Hagerstown, Md. : 1997)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W2891269224","https://openalex.org/W2902822641","https://openalex.org/W2972772484","https://openalex.org/W2980537150","https://openalex.org/W2980687050","https://openalex.org/W3204244377","https://openalex.org/W3210474759"],"related_works":["https://openalex.org/W4310859953","https://openalex.org/W3166164116","https://openalex.org/W4394754447","https://openalex.org/W3176717465","https://openalex.org/W7124888283","https://openalex.org/W3021289189","https://openalex.org/W2954354704","https://openalex.org/W3120843647","https://openalex.org/W4395066730","https://openalex.org/W4412185208"],"abstract_inverted_index":{"Immune":[0],"checkpoint":[1],"inhibitors":[2],"(ICI)":[3],"have":[4],"gained":[5],"approval":[6],"as":[7,48,58,137],"a":[8,11,71,145],"treatment":[9,87,113],"for":[10,27,95,161],"wide":[12],"array":[13],"of":[14,18,23,34,62,73,97,102,108,134,149],"cancers.":[15],"Their":[16],"mechanism":[17,168],"action":[19],"prevents":[20],"the":[21,32,35,81,106,111,132,167],"inactivation":[22],"cytotoxic":[24,29],"T-cells,":[25],"allowing":[26],"its":[28,153],"response.":[30],"However,":[31],"upregulation":[33],"immune":[36],"system":[37],"by":[38],"ICI":[39,121,150],"also":[40],"leads":[41],"to":[42,60,65,80,86,143,155],"many":[43],"undesired":[44],"adverse":[45,50],"events":[46,51],"known":[47],"immune-related":[49],"(irAEs),":[52],"ranging":[53],"from":[54],"dermatologic":[55],"manifestations,":[56],"such":[57],"rashes,":[59],"inflammation":[61],"mucous":[63],"membranes,":[64],"hematologic":[66,103,109],"toxicities.":[67],"Here,":[68],"we":[69,126],"report":[70,141],"case":[72,140],"ICI-induced":[74],"pure":[75],"white":[76],"cell":[77],"aplasia,":[78],"secondary":[79],"agent":[82],"durvalumab,":[83],"which":[84],"responded":[85],"with":[88],"filgrastim,":[89],"prednisone,":[90],"and":[91,151,164],"cyclosporine.":[92],"ICI-neutropenia":[93],"accounts":[94],"0.6%":[96],"all":[98],"irAEs":[99,136],"or":[100],"17%":[101],"irAEs.":[104,171],"Given":[105],"rarity":[107],"irAEs,":[110],"available":[112],"guidelines":[114],"are":[115],"based":[116],"on":[117],"expert":[118],"consensus.":[119],"As":[120],"becomes":[122],"more":[123],"widely":[124],"used,":[125],"can":[127],"expect":[128],"an":[129],"increase":[130],"in":[131],"prevalence":[133],"rare":[135,146],"well.":[138],"This":[139],"aims":[142],"present":[144],"side":[147],"effect":[148],"demonstrate":[152],"response":[154],"immunosuppressive":[156],"therapy":[157],"while":[158],"providing":[159],"guidance":[160],"future":[162],"clinicians":[163],"further":[165],"elucidating":[166],"behind":[169],"these":[170]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2023-11-01T00:00:00"}